1. Anderson P, Smith DH: Isolation of the capsular polysaccharide from the culture supernatant of Haemophilus influenzae b. Infect Immun 1977; 15: 472–477.
2. Austrian R, Douglas RM, Schiffman G, et al: Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physician 1976; 89: 184–194.
3. Ayme G, Donikian R, Mynard MC, Lagrandeur G: Production and controls of serogroup A Neisseria meningitidis polysaccharide vaccine, in Table Ronde sur l’Immunoprophylaxie de la Méningite Cérébrospinale, Saint-Paul de Vence, France. Lyon, Fondation Mérieux, 1973, pp 4–30.
4. Cadoz M, Armand J, Arminjon F, et al: A new 23 valent pneumococcal vaccine: immunogenicity and reactogenicity in adults. J Biol Stand 1985; 13: 261–265.
5. Cadoz M, Arminjon F, Quentin-Millet MJ, Armand J: Safety and immunogenicity of Mérieux acellular pertussis vaccines in adult volunteers. Presented at: Workshop on Acellular Pertussis Vaccines Organized by the Interagency Group to Monitor Vaccine Development, CDC, FDA, NIH. Bethesda, 1986.